Go to India” May Be a Key Market for Pharma Companies following its Government's Thumbs-up to the AU, EU, UK, and US Regulatory Review for Certain Drugs.
Gil Bashe is the Editor-in-Chief for Medika Life and FINN Partners. With a focus on health innovation and patient care, Gil's articles cover a wide range of topics including biopharma, digital health, and ecohealth. He is a strong advocate for bridging the divide between public and private sectors and championing pressing issues in healthcare.